Pirfenidone And Nintedanib Tips For Treating Patients With Idiopathic Pulmonary

Pirfenidone and Nintedanib Tips for Treating Patients with Idiopathic Pulmonary

Bolton Pulmonary Fibrosis Support Group

Overview of Pirfenidone and Nintedanib | Joyce Lee, MD

Pulmonary Fibrosis Foundation

Perspective on Side Effect Management Strategies with Pirfenidone and Nintedanib

The France Foundation

Pharmacologic Therapy | Charlene Fell, MD, MSc

Pulmonary Fibrosis Foundation

Safety and Management of Side Effects of Pirfenidone and Nintedanib | Wendi Mason, MSN

Pulmonary Fibrosis Foundation

Treatment Part B: Adverse Reactions Pirfenidone & Nintedanib - Interstitial Lung Disease

Annenberg Center for Health Sciences

Can Pulmonary Rehabilitation Help Patients with Idiopathic Pulmonary Fibrosis?

Idiopathic Pulmonary Fibrosis - 2018

Evaluating New Advances in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Antifibrotic treatment in Pulmonary Fibrosis

Dr. Stefan Cristian Stanel

Idiopathic Pulmonary Fibrosis: Pirfenidone

Demystifying Medicine McMaster

Discovering New Drugs for IPF

The France Foundation

Idiopathic Pulmonary Fibrosis: Management & Treatment

Demystifying Medicine McMaster

Safety & Efficacy of Pirfenidone for IPF - Part 1

IPF Treatment: Starting on Pirfenidone

PlatformQ Health

Impact Of Patient Education And Follow Up With Pirfenidone In Patients With IPF

The France Foundation

What is the BEST treatment for pulmonary fibrosis ?

Interstitial Lung Disease Info

Treatments for Pulmonary Fibrosis

Pulmonary Fibrosis Foundation

Nintedanib in Japanese patients with IPF: A subgroup analysis of the INPULSIS® randomized trials

Respirology Video

Idiopathic Pulmonary Fibrosis Epidemiology and Management